NANNI, JACOPO
 Distribuzione geografica
Continente #
AS - Asia 1.285
NA - Nord America 1.069
EU - Europa 830
AF - Africa 113
SA - Sud America 82
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.385
Nazione #
US - Stati Uniti d'America 1.053
CN - Cina 419
SG - Singapore 404
IT - Italia 289
VN - Vietnam 143
GB - Regno Unito 111
KR - Corea 94
HK - Hong Kong 90
DE - Germania 84
SE - Svezia 84
NL - Olanda 64
BR - Brasile 60
IN - India 58
CI - Costa d'Avorio 36
RU - Federazione Russa 34
IE - Irlanda 30
SC - Seychelles 27
TG - Togo 26
FR - Francia 24
FI - Finlandia 20
JP - Giappone 20
AT - Austria 15
BG - Bulgaria 15
JO - Giordania 15
NG - Nigeria 13
ID - Indonesia 12
ES - Italia 11
PL - Polonia 8
ZA - Sudafrica 8
CA - Canada 7
CH - Svizzera 7
EC - Ecuador 7
AR - Argentina 6
BE - Belgio 6
TR - Turchia 6
EE - Estonia 5
IR - Iran 5
LT - Lituania 5
MX - Messico 5
AU - Australia 4
GR - Grecia 4
UZ - Uzbekistan 4
BD - Bangladesh 3
CL - Cile 3
IQ - Iraq 3
CZ - Repubblica Ceca 2
HR - Croazia 2
PY - Paraguay 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
CO - Colombia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.385
Città #
Singapore 289
Hefei 157
Ashburn 147
Chandler 110
Seoul 94
Hong Kong 89
Southend 86
Dallas 83
Bologna 53
Ann Arbor 52
Fairfield 48
Milan 44
Abidjan 36
Ho Chi Minh City 36
Hanoi 34
Beijing 33
Santa Clara 32
Dublin 30
Boardman 27
Lomé 26
Princeton 26
New York 24
Seattle 19
Houston 18
Wilmington 18
Cambridge 17
Tokyo 17
Amman 15
Bengaluru 15
Los Angeles 15
Sofia 15
Rome 13
Abeokuta 12
Redmond 12
Redondo Beach 12
Woodbridge 12
Helsinki 11
Frankfurt am Main 10
Vienna 10
Bremen 9
Buffalo 9
Florence 9
Jakarta 9
Nanjing 9
Turin 9
Orlando 8
Tianjin 8
Biên Hòa 7
Falkenstein 7
Munich 7
Nuremberg 7
Phoenix 7
Shanghai 7
São Paulo 7
Zhengzhou 7
Amsterdam 6
Castel Maggiore 6
Guangzhou 6
London 6
Modena 6
Quận Bình Thạnh 6
Reggio Emilia 6
Atlanta 5
Berlin 5
Brussels 5
Bắc Ninh 5
Irvine 5
Lappeenranta 5
Mannheim 5
Medford 5
Ninh Bình 5
San Diego 5
Shijiazhuang 5
Westminster 5
Ankara 4
Chengdu 4
Chennai 4
Chicago 4
Forlì 4
Hyderabad 4
Madrid 4
Osimo 4
Padova 4
Quito 4
Shenyang 4
Tongling 4
Warsaw 4
Bern 3
Brasília 3
Brooklyn 3
Can Tho 3
Castel Madama 3
Catania 3
Council Bluffs 3
Dehradun 3
Des Moines 3
Ha Long 3
Haiphong 3
Hebei 3
Hải Dương 3
Totale 2.116
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 224
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 218
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 194
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 191
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 187
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 167
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 166
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 166
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 156
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents 151
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 150
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 144
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 137
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 133
NEXT GENERATION SEQUENCING FOR MINIMAL RESIDUAL DISEASE MEASUREMENT IN THE DAILY CLINICAL MANAGEMENT OF PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IS FEASIBLE AND PROVIDES USEFUL CLINICAL DATA. 132
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 121
Safety Run-In and Part 1 of GIMEMA AML1718: Venetoclax Combined with FLAI as Induction Treatment in Non-Low-Risk AML 116
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 106
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 104
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 97
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 95
Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a 94
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 86
Editorial: Precision medicine for acute myeloid leukemia 81
Acute myeloid leukemia mutations: Therapeutic implications 33
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia 21
Totale 3.470
Categoria #
all - tutte 10.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 3 1 16 11 3 8 16
2021/2022340 7 3 8 19 27 14 10 45 19 42 91 55
2022/2023500 52 73 22 41 55 42 9 38 90 9 42 27
2023/2024222 6 22 9 28 11 40 9 26 14 20 29 8
2024/2025858 38 130 56 59 51 36 99 43 19 91 75 161
2025/20261.263 294 374 183 217 155 40 0 0 0 0 0 0
Totale 3.470